Literature DB >> 8143619

Mutagenicity testing of 9-N-substituted adenines and their N-oxidation products.

J W Gorrod1, C Ioannides, S P Lam, S Neville.   

Abstract

Adenine together with certain 9-N-substituted derivatives such as 9-methyl, 9-benzyl, 9-benzhydryl, and 9-trityl were tested against Salmonella typhimurium strains TA97, TA98, and TA100 in the absence and presence of rat hepatic S9 prepared from Aroclor 1254 pretreated rats. All compounds were positive toward TA98 in the presence of the metabolic activating system, whereas they all lacked mutagenic activity in the absence of S9, and toward TA97 and TA100 with or without S9 when tested at 100 ng/plate. A similar pattern was observed for the corresponding 1-N-oxides. 6-Hydroxylaminopurine was not mutagenic toward TA100 at 100 ng/plate, whereas it was toxic toward TA97 and TA98 at this level. When tested at 1 ng/plate, hydroxylaminopurine was still toxic to TA98 but produced twice the spontaneous reversion rate to TA97 without metabolic activation. Surprisingly, 9-methyl-6-hydroxylaminopurine was only active toward TA98 in the presence of S9, whereas 9-benzyl-6-hydroxylaminopurine was highly active toward TA97 and TA100 in the absence of S9 and even more active in the presence of S9. This compound was inactive toward TA98 in the absence of S9. The results generally support the concept that nuclear N-oxidation of aminoazaheterocycles is a detoxication process, whereas N-hydroxylation of the exo amino group is a toxication reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8143619      PMCID: PMC1521118          DOI: 10.1289/ehp.93101s321

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  22 in total

1.  Biological N-oxidation of adenine and 9-alkyl derivatives.

Authors:  S P Lam; F Devinsky; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

2.  Oncogenic purine N-oxide derivatives as substrates for sulfotransferase.

Authors:  J J McDonald; G Stöhrer; G B Brown
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

3.  Revised methods for the Salmonella mutagenicity test.

Authors:  D M Maron; B N Ames
Journal:  Mutat Res       Date:  1983-05       Impact factor: 2.433

4.  Mutagens-carcinogens in foods.

Authors:  T Sugimura; S Sato
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

5.  Mutagenicity of derivatives of the oncogenic purine N-oxides.

Authors:  R W McCuen; G Stöhrer; F M Sirotnak
Journal:  Cancer Res       Date:  1974-02       Impact factor: 12.701

6.  Transversion-specific purine analogue mutagens and the mechanism of hydroxylaminopurine mutagenesis.

Authors:  V Murray
Journal:  Mutat Res       Date:  1987-04       Impact factor: 2.433

7.  Carcinogenic N-hydroxylaminopurine derivatives do not act as base analog mutagens in Salmonella typhimurium.

Authors:  M McCartney; E C McCoy; H S Rosenkranz; A Giner-Sorolla
Journal:  Mutat Res       Date:  1985-12       Impact factor: 2.433

Review 8.  Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates.

Authors:  R Kato
Journal:  Crit Rev Toxicol       Date:  1986       Impact factor: 5.635

9.  Biochemical studies on the mutagen, 6-N-hydroxylaminopurine. Synthesis of the deoxynucleoside triphosphate and its incorporation into DNA in vitro.

Authors:  M T Abdul-Masih; M J Bessman
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

10.  N-hydroxylation of carcinogenic and mutagenic aromatic amines.

Authors:  R Kato; T Kamataki; Y Yamazoe
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

View more
  2 in total

1.  Metabolism of 9-(2-chlorobenzyl)-, 9-(2-methylbenzyl)- and 9-(2-methoxybenzyl)-adenines by hamster hepatic microsomes.

Authors:  D Y Liu; Z D Liu; K el-Ghomari; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

2.  Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?

Authors:  Alexander Amberg; Lennart T Anger; Joel Bercu; David Bower; Kevin P Cross; Laura Custer; James S Harvey; Catrin Hasselgren; Masamitsu Honma; Candice Johnson; Robert Jolly; Michelle O Kenyon; Naomi L Kruhlak; Penny Leavitt; Donald P Quigley; Scott Miller; David Snodin; Lidiya Stavitskaya; Andrew Teasdale; Alejandra Trejo-Martin; Angela T White; Joerg Wichard; Glenn J Myatt
Journal:  Mutagenesis       Date:  2019-03-06       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.